Phase IB/II Trial of Lenvatinib Plus Pembrolizumab in Patients With Advanced Renal Cell Carcinoma, Endometrial Cancer, and Other Selected Advanced Solid Tumors - Taylor, M H; Lee, C H; Makker, V (J Clin Oncol, 2020)